FDA Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers – New York Times
New York Times |
FDA Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers
New York Times 23andMe headquarters in Mountain View, Calif. The Food and Drug Administration said on Thursday that it would allow the company to sell genetic tests directly to consumers. Credit Kristoffer Tripplaar/Sipa Press. For the first time, the Food and Drug … FDA Approves 23andMe’s At-Home DNA Tests for 10 Diseases At-home genetic test for 10 diseases gets first FDA approval 23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk |
View original article
Author:
Powered by WPeMatico